DEBORAH COHAN: Open Payments
NPI 1982832671 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 31 payments from 6 companies in 2025. Trend: 2023 $1,374 · 2024 $709 · 2025 $919
Food & beverage: $863Education: $56
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 16 | $514 |
| GlaxoSmithKline, LLC. | 7 | $175 |
| GENZYME CORPORATION | 3 | $96 |
| AstraZeneca Pharmaceuticals LP | 3 | $82 |
| Invivyd Inc | 1 | $27 |
| Amgen Inc. | 1 | $26 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, PEMGARDA, TRELEGY ELLIPTA.
Industry payments across MA — which companies pay providers there.
